Skip to main content
CAS 0 records

CAS 102-37-4

CAS 102-37-4 matches 0 EU annex records across Annex II–VI of Regulation 1223/2009.

Chemical identity and properties

PubChem 2D chemical structure for CAS 102-37-4
CAS 102-37-4PubChem CID 5317238

Ethyl Caffeate

Ethyl trans-caffeate is an ethyl ester resulting from the formal condensation of the carboxy group of trans-caffeic acid with ethanol. It has a role as an antineoplastic agent and an anti-inflammatory agent. It is an ethyl ester and an alkyl caffeate ester. It is functionally related to a trans-caffeic acid. — ChEBI

IUPAC name
ethyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Molecular formula
C11H12O4
Molecular weight
208.21 g/mol
Exact mass
208.07355886 Da
XLogP3
2.6
Topological polar surface area
66.8 Ų
Hydrogen-bond donors
2
Hydrogen-bond acceptors
4
Covalent units
1
Defined stereocentres
0

Also known as

ethyl trans-caffeateEthyl 3,4-dihydroxycinnamateCaffeic acid ethyl ester76GBB1JU5YCHEBI:132714RefChem:596426108-430-1Ethyl 3-(3,4-dihydroxyphenyl)acrylate
16 more reported names
(E)-Ethyl Dihydroxycinnamate(E)-ethyl caffeate4gqqEthyl (2e)-3-(3,4-Dihydroxyphenyl)prop-2-Enoate(E)-ethyl 3-(3,4-dihydroxyphenyl)acrylateHY-N6966NSC-619661AC-34380ethyl 3-(3,4-dihydroxyphenyl)prop-2-enoate2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, ethyl ester3-(3,4-Dihydroxy-phEthyl (E)-3-(3,4-dihydroxyphenyl)acrylateUNII-76GBB1JU5Y3,4-Dihydroxycinnamic acid ethyl ester3-(3,4-Dihydroxy-phenyl)-acrylic acid ethyl esterEthyl caffeate [M+H]+
External database identifiers

Evidence from additional scientific databases

EMBL-EBI ChEBI
Exact identifier matchCHEBI:132714

ethyl trans-caffeate

An ethyl ester resulting from the formal condensation of the carboxy group of trans-caffeic acid with ethanol.

Formula
C11H12O4
Average mass
208.213 g/mol
Monoisotopic mass
208.07356 Da
Formal charge
0
  • alkyl caffeate ester — is a (CHEBI:65331)
  • ethyl ester — is a (CHEBI:23990)
  • anti-inflammatory agent — has role (CHEBI:67079)
  • antineoplastic agent — has role (CHEBI:35610)
  • trans-caffeic acid — has functional parent (CHEBI:16433)
  • anti-inflammatory agent — has role (CHEBI:67079)
  • antineoplastic agent — has role (CHEBI:35610)
  • alkyl caffeate ester — is a (CHEBI:65331)
  • ethyl ester — is a (CHEBI:23990)
Additional curated names
ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoateethyl (2E)-3-(3,4-dihydroxyphenyl)acrylateethyl 3,4-dihydroxycinnamateethyl caffeate(E)-ethyl 3-(3,4-dihydroxyphenyl)acrylate(E)-ethyl 3,4-dihydroxycinnamate(E)-ethyl caffeate
Cross-references from this source
  • CAS: 102-37-4 — ChemIDplus
  • REGISTRY_NUMBER: 2106401 — Reaxys
  • MANUAL_X_REF: 5317238 — PubChem Compound
  • MANUAL_X_REF: Ethyl_caffeate — Wikipedia

Mapped by: Exact CAS cross-reference in the ChEBI compound record. Source updated: 2016-08-04. Retrieved: 2026-08-31. Open source record

NIH PubChem PUG-View
Exact identifier match5317238

Attributed physical-property, hazard, environmental and use annotations.

  • Signal: Warning Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (20%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (80%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (80%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (80%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 5 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. Source: European Chemicals Agency (ECHA)

Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record

Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.

Additional source coverage and match status
SourceResultChecked
EMBL-EBI ChEBIExact match2026-08-31
NIH PubChem PUG-ViewExact match2026-08-31

A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Records for CAS 102-37-4

0 total
No records found for this CAS number.

How CAS 102-37-4 is used on this site

CAS 102-37-4 is the Chemical Abstracts Service identifier used to pin this page to a specific substance. In the current dataset, 0 EU annex records share this identifier, which helps you cross-check whether the same substance appears under one regulatory context or several.

Use this page when a supplier specification, SDS or raw-material dossier gives you CAS 102-37-4 and you need to see every linked Annex II–VI record in one place. The entry cards above are the quickest route to concentration limits, warnings, annex placement and product-type conditions.